Biography and Research Information
OverviewAI-generated summary
Kate Janda's research focuses on the diagnostic features and interpretative pitfalls associated with specific cellular observations in dermatological conditions. Her work includes an investigation into "Dark Paget" cells within extramammary Paget disease of the vulva, as published in 2026. Additionally, she has studied BAP1 loss in carcinoma ex pleomorphic adenoma, with a publication in 2025. Janda collaborates with researchers at the University of Arkansas for Medical Sciences, including Jacob T. Wooldridge, Mugahed Hamza, Susanne K. Jeffus, and Brannon Broadfoot, with whom she has co-authored publications.
Metrics
- Publications: 2
Selected Publications
-
383 “Dark Paget” Cells in Extramammary Paget Disease of the Vulva – Diagnostic Features and Interpretative Pitfalls (2026)
-
1147 BAP1 Loss in Carcinoma ex Pleomorphic Adenoma (2025)
Collaboration Network
Top Collaborators
- 1147 BAP1 Loss in Carcinoma ex Pleomorphic Adenoma
- 1147 BAP1 Loss in Carcinoma ex Pleomorphic Adenoma
- 1147 BAP1 Loss in Carcinoma ex Pleomorphic Adenoma
- 1147 BAP1 Loss in Carcinoma ex Pleomorphic Adenoma
- 1147 BAP1 Loss in Carcinoma ex Pleomorphic Adenoma
- 383 “Dark Paget” Cells in Extramammary Paget Disease of the Vulva – Diagnostic Features and Interpretative Pitfalls
- 383 “Dark Paget” Cells in Extramammary Paget Disease of the Vulva – Diagnostic Features and Interpretative Pitfalls
- 383 “Dark Paget” Cells in Extramammary Paget Disease of the Vulva – Diagnostic Features and Interpretative Pitfalls
- 383 “Dark Paget” Cells in Extramammary Paget Disease of the Vulva – Diagnostic Features and Interpretative Pitfalls
Similar Researchers
Based on overlapping research topics